Institution statistics

ACADEMISCH ZIEKENHUIS LEIDEN - Netherlands 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:62
Total Number of Projects:100-200
Networking Rank (Reputation):100-200
2015
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:400-500
Project Leadership Index:100-200
Ranking timeline:

European project participation (2000-01-01 - 2018-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 119
As coordinator: 16
As participant: 90
Sole participant: 13
Coordinator / Participant Ratio: 0.18*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 7.996.372 11.837.194 3.479.546 5 3
2017 520.473 71.064.478 12.119.719 1 13
2016 22.489.460 203.325.598 14.253.311 3 14
2015 20.858.519 96.936.243 11.471.994 7 16
2012 4.124.081 20.595.868 3.350.441 3 5
2011 18.085.923 119.079.884 9.281.990 3 18
2010 4.357.784 85.218.036 5.215.112 4 10
2007 0 424.732 84.946 1
2006 0 1.400.000 127.273 1
2004 5.456.595 0 459.999 3
2002 0 7.630.882 1.023.762 5
2001 0 2.397.490 732.524 2
2000 0 3.899.803 514.262 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD20
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE16
KAROLINSKA INSTITUTE15
KATHOLIEKE UNIVERSITEIT LEUVEN13
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM12
UNIVERSITY COLLEGE LONDON12
STICHTING KATHOLIEKE UNIVERSITEIT11
UNIVERSITY OF COPENHAGEN11
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE10
COMMISSARIAT A L'ENERGIE ATOMIQUE10
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE10
KING'S COLLEGE LONDON10
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE10
DEPARTMENT OF HEALTH9
INSTITUT PASTEUR9
MEDICAL RESEARCH COUNCIL9
UNIVERSITAET ZUERICH9
EBERHARD KARLS UNIVERSITAET TUEBINGEN8
ISTITUTO SUPERIORE DI SANITA8
THE UNIVERSITY OF MANCHESTER8
UNIVERSITE LIBRE DE BRUXELLES8
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS7
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE7
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH7
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V7
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN7
LUNDS UNIVERSITET7
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV7
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS7
UNIVERSITE D'AIX MARSEILLE7
UNIVERSITE DE GENEVE7
UNIVERSITEIT LEIDEN7
UNIVERSITY OF OSLO7
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT6
INSTITUT CURIE6
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE6
MEDIZINISCHE HOCHSCHULE HANNOVER6
RUPRECHT KARLS UNIVERSITAET HEIDELBERG6
STATENS SERUM INSTITUT6
UNIVERSITA DEGLI STUDI DI MILANO6
UNIVERSITY OF GLASGOW6
UNIVERSITY OF SOUTHAMPTON6
UPPSALA UNIVERSITET6
ACADEMISCH ZIEKENHUIS GRONINGEN5
EUROPEAN MOLECULAR BIOLOGY LABORATORY5
HEALTH PROTECTION AGENCY5
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT5
THE UNIVERSITY OF EDINBURGH5
THE UNIVERSITY OF LIVERPOOL5
THE UNIVERSITY OF SHEFFIELD5
UNIVERSITA DEGLI STUDI DI PADOVA5
UNIVERSITA DEGLI STUDI DI SIENA5
UNIVERSITAET ULM5
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF5
UNIVERSITAT DE BARCELONA5
UNIVERSITE DE LAUSANNE5
UNIVERSITEIT GENT5
UNIVERSITEIT UTRECHT5
UNIVERSITY OF LEEDS5
UNIVERSITY OF WALES CARDIFF5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM4
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS4
FONDAZIONE PER L'ISTITUTO DI RICERC A IN BIOMEDICINA4
GENOMIC INVESTMENTS BV4
GENOS DOO ZA VJESTACENJE I ANALIZU4
INSTITUT GUSTAVE ROUSSY4
INSTITUT PASTEUR DE LILLE4
INSTITUTE OF EXPERIMENTAL MEDICINE HUNGARIAN ACADEMY OF SCIENCES4
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER4
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV4
MEDIZINISCHE UNIVERSITAT INNSBRUCK4
OSPEDALE SAN RAFFAELE4
REGION HOVEDSTADEN4
STICHTING VU4
TECHNISCHE UNIVERSITAET DRESDEN4
UNIVERSITAET BERN4
UNIVERSITAETSKLINIKUM AACHEN4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITEIT ANTWERPEN4
UNIVERSITEIT MAASTRICHT4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
UNIVERSITY OF ABERDEEN4
UNIVERSITY OF BIRMINGHAM4
UNIVERSITY OF HELSINKI4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
CENTRE DE RECHERCHES MEDICALES DE LAMBARENE3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
CONSIGLIO NAZIONALE DELLE RICERCHE3
DANISH CANCER SOCIETY3
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON3
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE3
FUNDACAO D ANNA SOMMER CHAMPALIMAUD E DR CARLOS MONTEZ CHAMPALIMAUD3
FUNDACION HOSPITAL LA FE3
GLAXOSMITHKLINE BIOLOGICALS3
GOETEBORGS UNIVERSITET3
HEINRICHHEINEUNIVERSITAET DUESSELDORF3
HOSPITAL CLINIC BARCELONA3
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE3
ISTITUTO NAZIONALE MALATTIE INFETTIVE LSPALLANZANI IRCCS3
Constancy:

Total number of partners:1584

Partner loyalty:
Frequent Partner: (> 2 projects): 712
Rare Partner: 872

Frequent / Rare Partner Ratio: 0.82

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES39
RTD HORIZONTAL TOPICS23
SOCIAL AND ECONOMIC CONCERNS14
PROTECTING MAN AND HIS ENVIRON7
INDUSTRY AND TECHNOLOGY4
AGRICULTURE AND MARINE RESOURC2
MEASUREMENTS AND STANDARDS1
ENERGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2018-07-01Investigation of a novel immune cell type in Tuberculosis: characterization of the specificity, function and pathogen killing ability of T cells restricted by non-classical HLA-E molecules MTBHLAEcoordinator165.5991
2018-07-01Function of DUX4 in skeletal muscle and non-muscle tissues DUX4coordinator177.5991
2018-03-01Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life CANCERparticipant2.430.00017
2018-03-01Development of an innovative Airway-on-Chip microbiome cell culture model to investigate host-microbiome interactions at the airway epithelial surface EpiCBiomecoordinator162.8652
2018-01-01European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets UbiCODEparticipant3.407.19411
2018-01-01Protein nano-patterning using DNA nanotechnology; control of surface-based immune system activation BioNanoPatterncoordinator1.499.8501
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBcoordinator5.990.46017
2018-01-01Transfer of multivirus-specific T-cells following transplantation TRACEparticipant6.000.0008
2017-12-01Developing Geroprotectors to Prevent Polymorbidity GeroProtectparticipant2.500.0002
2017-12-01Soraprazan - a new regenerative therapy for Stargardt's disease Soraprazanparticipant5.792.4257
2017-10-01Organ on Chip in Development ORCHIDcoordinator520.4736
2017-10-01Analytics for Biologics A4Bparticipant3.933.61711
2017-09-01The role of complement in the induction of autoimmunity against post-translationally modified proteins AUTOCOMPLEMENTparticipant1.999.8031
2017-09-01Improving Genome Editing Efficiency (IMGENE) IMGENEparticipant2.068.4097
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-07-01Oogenesis spotlighted: making mature human oocytes OVO-GROWTHparticipant2.000.0001
2017-06-12SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE VSV-EBOPLUSparticipant8.553.75010
2017-05-01European Vaccine Research and Development Infrastructure TRANSVAC2participant10.599.99326
2017-04-01Innovative training in methods for future data IMforFUTUREparticipant2.864.7618
2017-03-01Biological auto-detection and termination of heart rhythm disturbances Bio-ICDparticipant1.485.0281
2017-01-01IN SITU IMAGING OF LIVING TISSUES WITH CELLULAR SPATIAL RESOLUTION HISTO-MRIparticipant3.216.2505
2017-01-01Optimizing a deployable high efficacy malaria vaccine OptiMalVaxparticipant20.050.44116
2016-11-01Recirculated tissue macrophages (TiMa) in blood: Novel approach to early diagnosis and treatment monitoring in oncology TiMaScanparticipant2.500.0001
2016-10-01Exploitation of Glycosylation Signatures for Precision Medicine GlySigncoordinator1.552.8463
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20953
2016-09-01The ER located master regulation of endosomal positioning and further movements ERCOPEparticipant2.383.6251
2016-08-10PERtussIS COrrelates of Protection Europe PERISCOPEparticipant21.000.00020
2016-07-20Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification RHAPSODYparticipant8.130.00022
2016-06-01Advancing Smart Optical Imaging and Sensing for Health ASTONISHparticipant5.895.04624
2016-04-01Human Brain Project Specific Grant Agreement 1 HBP SGA1participant89.000.000117
2016-02-01A novel 3D Stereoscopic e-learning SolutIon for theoretical Surgical Training SurgASSISTparticipant2.973.8684
2016-01-01An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century EU-ToxRiskparticipant27.798.29939
2016-01-01Resetting the THYRoid axis for prevention of AGE-related diseases and co-morbidities THYRAGEcoordinator6.000.0006
2016-01-01Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen U-PGxcoordinator14.936.61316
2016-01-01Advanced Regenerative and REStorative Therapies to combat corneal BLINDNESS ARREST BLINDNESSparticipant5.993.17813
2016-01-01New therapies for uveal melanoma UM Cure 2020participant6.183.45613
2016-01-01Boost Brittle Bones Before Birth BOOSTB4participant6.608.75512
2016-01-01DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) SCIDNETparticipant6.926.31312
2016-01-01Tools and TECHNOlogies for Breakthrough in hEArt Therapies TECHNOBEATparticipant5.968.8508
2015-12-10Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes. INNODIAparticipant17.630.00027
2015-12-01Beta Cell Generation by Stem Cell-Derived Implants in Diabetes BetaCellTherapyparticipant6.200.0007
2015-11-01Stem Cells for Cardiac Arrhythmia Risk Assessment STEMCARDIORISKparticipant1.500.0001
2015-11-01Novel materials to improve magnetic resonance imaging NOMA-MRIcoordinator2.263.6921
2015-10-30Human Brain Project Framework Partnership Agreement HBP FPAparticipant086
2015-10-01Free Respiratory Evaluation and Smoke-exposure reductionby primary Health cAre Integrated gRoups FRESH AIRcoordinator2.990.75015
2015-10-01implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC ADOPT BBMRI-ERICparticipant4.949.44919
2015-09-01Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study MOGLYNETparticipant3.086.4365
2015-09-01Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) BRIDGEScoordinator6.200.00018
2015-09-01A Clinical Decision Support system based on Quantitative multimodal brain MRI for personalized treatment in neurological and psychiatric disorders CDS-QUAMRIparticipant2.168.1257
2015-09-01Infrastructure for NMR, EM and X-rays for translational research iNEXTparticipant9.999.53425

overview shows latest 50 from 119 projects (2000-01-01 - 2018-12-31)
A full list of projects can be found here:
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: